文献速递创伤与烧伤复苏、休克与脓毒症

院前止血带用于穿透性四肢创伤:减少输血与肢体并发症

Prehospital tourniquet use in penetrating extremity trauma: Decreased blood transfusions and limb complications.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在穿透性四肢大血管创伤中,院前止血带与到达急诊时收缩压更高、输血更少及筋膜切开和截肢率更低相关。

该单中心8年回顾性分析纳入204例成人穿透性四肢严重创伤(大血管损伤、创伤性截肢及近截肢)患者,将院前使用止血带者(127例,62.3%)与匹配的未使用止血带者进行比较。止血带组到达急诊时平均收缩压更高(120±2 vs 112±2,p=0.003),需要更少的总红细胞悬液(2.0±0.1 vs 9.3±0.6,p<0.001)和新鲜冰冻血浆(1.4±0.08 vs 6.2±0.4,p<0.001)。止血带与神经麻痹(p=0.330)或继发感染(p=0.43)无关,未使用止血带组筋膜切开(31.4% vs 12.6%,p<0.0001)和截肢(9.1% vs 0.8%,p=0.005)发生率更高。作者认为院前止血带可安全用于穿透性四肢严重创伤控制出血,不增加主要并发症风险。

要点

  • 在穿透性四肢严重创伤中,院前使用止血带者到达急诊时平均收缩压更高(120±2 vs 112±2,p=0.003)。
  • 止血带组总红细胞悬液用量更少(2.0±0.1 vs 9.3±0.6,p<0.001),新鲜冰冻血浆用量也更少(1.4±0.08 vs 6.2±0.4,p<0.001)。
  • 未使用止血带组筋膜切开率更高(31.4% vs 12.6%,p<0.0001),截肢率也更高(9.1% vs 0.8%,p=0.005)。
  • 止血带与神经麻痹(p=0.330)或继发感染(p=0.43)无关。
  • 止血带从应用到到达急诊的平均时间为22.5±1.3分钟。

适用人群与场景

  • 成人穿透性四肢严重创伤,适合使用止血带者,包括大血管损伤、创伤性截肢及近截肢。
  • 单中心、I级创伤中心。

研究设计与关键结果

  • 研究类型:8年回顾性分析,单中心,204例匹配患者,院前止血带组127例(62.3%)。
  • 两组患者人口学特征或损伤严重程度无差异。
  • 止血带从应用到到达急诊的平均时间为22.5±1.3分钟。
  • 到达急诊时平均收缩压:止血带组120±2 vs 未使用止血带组112±2,p=0.003。
  • 总红细胞悬液用量:止血带组2.0±0.1 vs 未使用止血带组9.3±0.6,p<0.001。
  • 新鲜冰冻血浆用量:止血带组1.4±0.08 vs 未使用止血带组6.2±0.4,p<0.001。
  • 筋膜切开率:未使用止血带组31.4% vs 止血带组12.6%,p<0.0001。
  • 截肢率:未使用止血带组9.1% vs 止血带组0.8%,p=0.005。

证据类型、等级与局限

  • 证据类型:回顾性分析,治疗性研究,证据等级IV级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为院前止血带可安全用于穿透性四肢严重创伤控制出血,不增加主要并发症风险。
  • 作者认为院前止血带使用与到达急诊时收缩压升高、血液制品使用减少及肢体相关并发症发生率降低相关,可能改善长期结局和生存率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Despite increasing popularity of prehospital tourniquet use in civilians, few studies have evaluated the efficacy and safety of tourniquet use. Furthermore, previous studies in civilian populations have focused on blunt trauma patients. The objective of this study was to determine if prehospital tourniquet use in patients with major penetrating trauma is associated with differences in outcomes compared to a matched control group.

METHODS: An 8-year retrospective analysis of adult patients with penetrating major extremity trauma amenable to tourniquet use (major vascular trauma, traumatic amputation and near-amputation) was performed at a Level I trauma center. Patients with prehospital tourniquet placement (TQ) were identified and compared to a matched group of patients without tourniquets (N-TQ). Univariate analysis was used to compare outcomes in the groups.

RESULTS: A total of 204 patients were matched with 127 (62.3%) in the prehospital TQ group. No differences in patient demographics or injury severity existed between the two groups. Average time from tourniquet application to arrival in the emergency department (ED) was 22.5 ± 1.3 minutes. Patients in the TQ group had higher average systolic blood pressure on arrival in the ED (120 ± 2 vs. 112 ± 2, p = 0.003). The TQ group required less total PRBCs (2.0 ± 0.1 vs. 9.3 ± 0.6, p < 0.001) and FFP (1.4 ± 0.08 vs. 6.2 ± 0.4, p < 0.001). Tourniquets were not associated with nerve palsy (p = 0.330) or secondary infection (p = 0.43). Fasciotomy was significantly higher in the N-TQ group (12.6% vs. 31.4%, p < 0.0001) as was limb amputation (0.8% vs. 9.1%, p = 0.005).

CONCLUSION: This study demonstrated that prehospital tourniquets could be safely used to control bleeding in major extremity penetrating trauma with no increased risk of major complications. Prehospital tourniquet use was also associated with increased systolic blood pressure on arrival to the ED, decreased blood product utilization and decreased incidence of limb related complications, which may lead to improved long-term outcomes and increased survival in trauma patients.

LEVEL OF EVIDENCE: Therapeutic, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Smith AA, Ochoa JE, Wong S, et al. Prehospital tourniquet use in penetrating extremity trauma: Decreased blood transfusions and limb complications. J Trauma Acute Care Surg. 2019. PMID: 30358768. doi:10.1097/TA.0000000000002095

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。